ACTOnco®+

Comprehensive Cancer Genomic Profiling Service

Find the Right Treatment for Your Cancer Patient

ACTOnco^®+ is developed with the aim of supporting and answering the clinical challenges faced during the management of major solid tumors, including carcinomas, sarcomas, and lymphomas. ACTOnco^®+ panel comprises 440 specially-curated genes, 31 fusion genes & 182 fusion transcripts and references the Hallmarks of Cancer to facilitate treatment strategies, including:Chemotherapy, Targeted therapy, Immunotherapy and Pharmacogenomics.

Cancer Signaling Pathway Analysis-Identify more treatment options with pathway integration

ACTOnco^®+ comprehensively identifies genetic alterations of each signaling pathway to evaluate drug options based on upstream and downstream interactions. By incorporating comprehensive genomics profiling and integrating signaling pathway analysis, ACTOnco^® + provides clinicians with a more holistic understanding of the major cancer-driven events during tumorigenesis and provides more targeted therapeutic strategies.